Drug Profile
Sodium phenylbutyrate - Lucane Pharma
Alternative Names: Luc-01; Pheburane; Phenylbutyrate - Lucane PharmaLatest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator Lucane Pharma
- Developer Lucane Pharma; Medunik Canada; Orpharma
- Class Antineoplastics; Electrolytes; Phenylbutyrates; Small molecules
- Mechanism of Action Ammonia scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hyperammonaemia
Most Recent Events
- 06 Jun 2017 No recent reports on development identified - Registered for Hyperammonaemia (Adjunctive treatment) in Iceland and Liechtenstein (PO)
- 30 May 2017 Registered for Hyperammonaemia (Adjunctive treatment) in Australia (PO)
- 30 Mar 2015 Launched for Hyperammonaemia (Adjunctive treatment in patients with urea cycle disorders) in Canada (PO)